You are here : Home > PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

Publications CNRGH

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

Published on 2 October 2023
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Description
 
Date de publication14/03/2020
Auteurs
Kleineidam L, Chouraki V, Prochnicki T, van der Lee SJ, Madrid-Marquez L, Wagner-Thelen H, Karaca I, Weinhold L, Wolfsgruber S, Boland A, Martino Adami PV, Lewczuk P, Popp J, Brosseron F, Jansen IE, Hulsman M, Kornhuber J, Peters O, Berr C, Heun R, Frolich L, Tzourio C, Dartigues JF, Hull M, Espinosa A, Hernandez I, de Rojas I, Orellana A, Valero S, Stringa N, van Schoor NM, Huisman M, Scheltens P, Ruther E, Deleuze JF, Wiltfang J, Tarraga L, Schmid M, Scherer M, Riedel-Heller S, Heneka MT, Amouyel P, Jessen F, Boada M, Maier W, Schneider A, Gonzalez-Perez A, van der Flier WM, Wagner M, Lambert JC, Holstege H, Saez ME, Latz E, Ruiz A and Ramirez A
Revue
Année2,020
Département / Service
CNRGH
Laboratoire
LBanq
Impact Factor 
InstitutJACOB
url DOI10.1007/s00401-020-02138-6

Go back to list